Topical sulindac therapy in diabetic senile cataracts : cataract IV

Topical sulindac therapy in diabetic senile cataracts : cataract IV

Sulindac, a non-steroidal anti-inflammatory drug has been found to be a potent inhibitor of enzyme aldose reductase. We used sulindac topically in diabetic senile cataract patients to note if it effects the progression of cataracts. More of sulindac treated eyes maintained initial vision and fewer e...

Full description

Bibliographic Details
Main Authors: Sharma Y, Vajpayee R, Bhatnagar R, Mohan Madan, Azad R, Kumar Mukesh, Nath Ram
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 1989-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Sulindac
aldose reductase
dia-betic senile cataracts
prostaglandin pathways
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=1989;volume=37;issue=3;spage=127;epage=133;aulast=Sharma

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=1989;volume=37;issue=3;spage=127;epage=133;aulast=Sharma

Similar Items